Resumen en español

Se presenta una serie de 88 pacientes sometidos a inyección endoscópica por sangrado del tracto gastrointestinal superior en el Servicio de Endoscopia Digestiva del Hospital Universitario del Valle, Cali, entre 1994 y 1996. Se documentó úlcera gástrica en 55 (62.5%) y úlcera duodenal en 33 (37.5%). Del total de pacientes, 68 (77.3%) eran hombres y 20 (22.7%) mujeres, con edades entre 14 y 94 años, y promedio de 50.2 años. Se obtuvo historia de uso de antiinflamatorios no esteroideos en 27 (30.6%) y enfermedades intercurrentes en 23 (26.1%). De las lesiones tratadas endoscópicamente, 18 (20.5%) presentaban sangrado activo pulsátil, 31 (35%) escurrimiento y 39 (44.5%) vaso visible no sangrante. En todos los pacientes se utilizó inyección con solución de adrenalina 1:10,000. Se corroboró hemostasia en 48 (97.9%) de los 49 que presentaban sangrado activo. Se presentó resangrado en las primeras 72 horas en 21 (24%). Requirieron tratamiento quirúrgico 17 (19.3%) y fallecieron 9 (10%) del grupo total. En ninguno de los casos se informaron complicaciones asociadas con la terapia endoscópica. Esta experiencia es similar a las series publicadas en lo concerniente a resangrado agudo y mortalidad, esta última relacionada con entidades concurrentes y edad avanzada de los enfermos. We are presenting a series of 88 patients who consulted because of upper G-I bleeding to the Digestive Unit in the Hospital Universitario in Cali between I994 –96 and in whom endoscopic injection was carried out. Gastric ulcer was found in 55(62.5%) and duodenal ulcer in 33(37%).There were 68 (77.3%) men and 20 (37.5%) women with an age range between 14-94 years with an average of 50.2 years. There was a history of recent use of NSAIDs in 27(30.6%) and intercurrent diseases in 23 (26.1%). Of the lesions described endoscopically 18 (20.5%) had active or oozing bleeding, 31(35%) spurting and 39(44.5) non bleeding visible vessel. Injection with adrenaline 1:10000 was used in all of the patients. Ceasing of the bleeding was obtained in 48(97.9%) of the 49 who had active bleeding. Rebleeding occurred in 21(24%) during the first 72 hours. Seventeen (19.3%) required surgical treatment and nine (10%) died. There were no complications associated with the endoscopic therapy. This experience is similar to that published in the literature regarding acute rebleeding and mortality.